A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 17, 2025

Primary Completion Date

June 17, 2025

Study Completion Date

June 17, 2025

Conditions
Relapsed/Refractory Autoimmune Diseases
Interventions
BIOLOGICAL

LCAR-AIO T cells

Before treatment with LCAR-AIO T cells, subjects will receive a conditioning regimen.

Trial Locations (4)

Unknown

The First Affiliated Hospital of USTC (anhui provincial hospital), Hefei

Jiangsu Province Hospital, Nanjing

The 1st Affiliated Hospital of WHU, Wenzhou

The Affiliated Hospital of XUZHOU Medical University, Xuzhou

Sponsors
All Listed Sponsors
lead

Nanjing Legend Biotech Co.

INDUSTRY